% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Smith:141053,
author = {Smith, Eric E and Biessels, Geert Jan and De Guio,
François and de Leeuw, Frank Erik and Duchesne, Simon and
Düring, Marco and Frayne, Richard and Ikram, M Arfan and
Jouvent, Eric and MacIntosh, Bradley J and Thrippleton,
Michael J and Vernooij, Meike W and Adams, Hieab and Backes,
Walter H and Ballerini, Lucia and Black, Sandra E and Chen,
Christopher and Corriveau, Rod and DeCarli, Charles and
Greenberg, Steven M and Gurol, M Edip and Ingrisch, Michael
and Job, Dominic and Lam, Bonnie Y K and Launer, Lenore J
and Linn, Jennifer and McCreary, Cheryl R and Mok, Vincent C
T and Pantoni, Leonardo and Pike, G Bruce and Ramirez, Joel
and Reijmer, Yael D and Romero, Jose Rafael and Ropele,
Stefan and Rost, Natalia S and Sachdev, Perminder S and
Scott, Christopher J M and Seshadri, Sudha and Sharma, Mukul
and Sourbron, Steven and Steketee, Rebecca M E and Swartz,
Richard H and van Oostenbrugge, Robert and van Osch,
Matthias and van Rooden, Sanneke and Viswanathan, Anand and
Werring, David and Dichgans, Martin and Wardlaw, Joanna M},
title = {{H}armonizing brain magnetic resonance imaging methods for
vascular contributions to neurodegeneration.},
journal = {Alzheimer's $\&$ dementia / Diagnosis, assessment $\&$
disease monitoring},
volume = {11},
number = {1},
issn = {2352-8729},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {DZNE-2020-07375},
pages = {191-204},
year = {2019},
abstract = {Many consequences of cerebrovascular disease are
identifiable by magnetic resonance imaging (MRI), but
variation in methods limits multicenter studies and pooling
of data. The European Union Joint Program on
Neurodegenerative Diseases (EU JPND) funded the HARmoNizing
Brain Imaging MEthodS for VaScular Contributions to
Neurodegeneration (HARNESS) initiative, with a focus on
cerebral small vessel disease.Surveys, teleconferences, and
an in-person workshop were used to identify gaps in
knowledge and to develop tools for harmonizing imaging and
analysis.A framework for neuroimaging biomarker development
was developed based on validating repeatability and
reproducibility, biological principles, and feasibility of
implementation. The status of current MRI biomarkers was
reviewed. A website was created at
www.harness-neuroimaging.org with acquisition protocols, a
software database, rating scales and case report forms, and
a deidentified MRI repository.The HARNESS initiative
provides resources to reduce variability in measurement in
MRI studies of cerebral small vessel disease.},
subtyp = {Review Article},
cin = {München common / AG Levin},
ddc = {610},
cid = {I:(DE-2719)6000016 / I:(DE-2719)1111016},
pnm = {344 - Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30859119},
pmc = {pmc:PMC6396326},
doi = {10.1016/j.dadm.2019.01.002},
url = {https://pub.dzne.de/record/141053},
}